Budera P, et al. - Hybrid ablation of atrial fibrillation (AF) is a promising treatment strategy for patients with non-paroxysmal AF, although, data regarding mid-term outcomes are limited. In this present study, it was demonstrated that hybrid ablation of non-paroxysmal AF using a novel, versapolar RF device afforded promising mid-term outcomes. Furthermore, in AF patients, better arrhythmia-free survival rates were evident in association with shorter AF duration.